• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

pH-sensitive nanoparticles reduce cancer growth by deoxygenating tumor tissue [PreClinical]

byChristine YoonandJessica Lau
January 17, 2017
in Chronic Disease, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Under mildly acidic in vitro conditions, silicon-based nanoparticles (NPs) effectively scavenged dissolved and hemoglobin-bound oxygen (O2) and reduced breast cancer cell viability.  

2. In a mouse model of breast cancer, treatment with NPs reduced tumor tissue oxygenation and diminished tumor progression without detectable damage to vital organs.

Evidence Rating Level: 2 (Good)           

Study Rundown: Though starving tumors of O2 and nutrients has been regarded as an approach to impede rapid growth, feasible techniques to induce starvation remain elusive. In this work, oxygen-scavenging NPs were developed to deoxygenate tissues under acidic conditions and consequently block the proliferative capacity of tumors.

In vitro, mildly acidic environments activated the magnesium silicide (Mg2Si) NPs to produce reactive silane groups that acted as O2 scavenging molecules. In solutions with pH<6.5, NPs significantly reduced dissolved O2 levels to undetectable concentrations within several hours and maintained this effect for as long as 1 week. Additionally, the ability for NPs to deoxygenate solutions of oxyhemaglobin (oxyHb) was examined since most O2 is delivered in a hemoglobin-bound state. Treatment with NPs at pH 6.5 caused a significant loss of oxyHb and gain of deoxyhemaglobin (deoxyHb) whereas NPs in pH 7.4 incited no changes. In breast cancer cells exposed to NPs under acidic conditions, significant reduction in proliferation rate was accompanied with increased cell apoptosis. When tested in a mouse model of breast cancer, NP treatment significantly reduced O2 saturation levels and gross tumor growth over the course of 16 days. Importantly, NPs had undetectable negative effects on the tissue health of main organs such as the liver and lung.

This work provided promising preliminary evidence suggesting that tumor O2 starvation can be achieved through a nanotherapeutics approach. Long-term efficacy and safety must be evaluated to push this therapy into clinical use, especially since the oxygen-scavenging process generates microparticle by-products that can cause off-target organ damage.

Click to read the study in Nature Nanotechnology 

RELATED REPORTS

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

#StudyGraphics: Concomitant chemoradiotherapy improves survival in elderly adults with locally advanced head and neck squamous cell carcinoma

Risk model-based lung cancer screening is more cost effective than current practice

Relevant Reading: A review of stimuli-responsive nanocarriers for drug and gene delivery

In-Depth [animal study]: Mg2Si NPs were chemically synthesized and tested for their deoxygenating capabilities in buffered solutions with pH 7.4, 6.5, and 4.5. Dissolved O2 concentrations of the solutions were measured using an O2 microelectrode every several hours and up to 7 days after NP addition. While the O2 concentration remained unchanged at pH 7.4, O2 levels of the acidic solutions became undetectable within 8 hours and remained steady for 1 week. Deoxygenation of oxyHb by NPs was examined through the addition of fresh blood collected from female BALB/c mice into solutions with pH 7.4 and 6.5. Solution samples were analyzed using UV-vis spectroscopy, which indicated a loss in absorption peaks at 542nm and 577nm (oxyHb) and a gain of a band at 555nm (deoxyHb) in the mildly acidic condition.

Proliferation studies performed on MCF-7 breast cancer cells demonstrated that 2mM NP treatment led to a nearly 50% reduction in growth relative to the control (p<0.001). At higher NP doses (5mM and 10mM), negative proliferation rates were observed, suggesting cell death. Flow cytometry confirmed that high-dose NP treatment led to nearly 3-fold and 5-fold increases in apoptotic cells, respectively.

In the mouse experiment, BALB/c mice were bilaterally injected with 4T1 breast cancer cells 10 days before treatment. Intratumoral injection of NPs (1M) triggered a significant drop in tumor blood O2 saturation over several hours whereas the saline control produced no effect. In the 16 days after treatment, tumors given saline injections rapidly grew in volume whereas tumors with NP injections remained unchanged (p<0.001, n=5 per group). At the end of treatment, histological H&E staining of vital organs (heart, spleen, lung, liver, and kidney) demonstrated negligible changes to tissue structure.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancernanotechnology
Previous Post

Review suggests use of standard rather than intensive blood pressure treatment in the elderly

Next Post

Patient and provider interventions no better than usual care for osteoarthritis

RelatedReports

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Chronic Disease

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

March 20, 2023
#StudyGraphics: Concomitant chemoradiotherapy improves survival in elderly adults with locally advanced head and neck squamous cell carcinoma
StudyGraphics

#StudyGraphics: Concomitant chemoradiotherapy improves survival in elderly adults with locally advanced head and neck squamous cell carcinoma

March 9, 2023
Lessons from real-world implementation of lung cancer screening
Chronic Disease

Risk model-based lung cancer screening is more cost effective than current practice

February 20, 2023
Fatty liver disease may independently predict high-risk coronary disease
Chronic Disease

Adjuvant S-1 increases short-term survival in patients with resected biliary tract cancer

February 1, 2023
Next Post
Reduced gestational weight gain with lifestyle intervention

Patient and provider interventions no better than usual care for osteoarthritis

Tonsillectomy may have short-term benefits in recurrent throat infection

Tonsillectomy may have short-term benefits in recurrent throat infection

Decreased prevalence of HPV among vaccinated young females

Effectiveness of meningococcal conjugate vaccine wanes after 3-8 years

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Metformin use may decrease risk of osteoarthritis development
  • Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease
  • Expectant management of patent ductus arteriosus noninferior to early ibuprofen use
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options